Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.000
-0.330 (-7.62%)
At close: Apr 21, 2026, 4:00 PM EDT
3.990
-0.010 (-0.25%)
After-hours: Apr 21, 2026, 5:30 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.59 million as of April 21, 2026. Its market cap has increased by 163.87% in one year.
Market Cap
2.59M
Enterprise Value
-8.81M
1-Year Change
163.87%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.59M, a decrease of -97.46%. That is a compound annual growth rate of -40.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 2.81M | 47.43% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decoy Therapeutics | 3.09M |
| Calidi Biotherapeutics | 3.04M |
| Virax Biolabs Group | 2.99M |
| HCW Biologics | 2.94M |
| BiomX | 2.93M |
| SciSparc | 2.50M |
| Bone Biologics | 2.50M |
| Propanc Biopharma | 2.33M |